Pliant Therapeutics

0 followers


Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

Industries

Headquarters

Stage

Employees

Links

Org chart

Hiring!

Bernard Coulie
President & CEO

Bernard Coulie

Collapse
Éric Lefebvre
Chief Medical Officer
Hans Hull
Chief Business Officer
Lily Cheung
Chief Human Resources Officer
Minnie Kuo
Chief Development Officer
Mike Ouimette
General Counsel & Corporate Secretary
Shuguang Zhu
SVP, Chemistry, Manufacturing & Controls
Christopher Keenan
VP, Investor Relations & Corporate Communications
Eve-Irene Lepist
VP, Non-Clinical Development
Fernando Rock
VP, Drug Discovery
Monica Sandberg
VP, Regulatory Affairs
Tim Machajewski
VP, Chemistry
Andrew You
VP, Program Team Lead & Portfolio Management
Martin Decaris
Sr. Director, Translational Sciences
Avid Hassanpour
Senior Research Scientist I, Medicinal Chemistry
Diane Ireland
Associate Director Facilities And Eh&s